Lacdayeng, Jack Cyves .

HRN: 29-01-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/15/2026
06/21/2026
IV
450mg
Q8hours
PCAP-C; T/c HAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines